Bristol-Myers Squibb

$66.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+0.30%) Today

+$0.25 (+0.37%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BMY and other stocks, options, and ETFs commission-free!

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. The listed name for BMY is Bristol-Myers Squibb Co.

CEO

Giovanni Caforio

Employees

30,000

Headquarters

New York, New York

Founded

1933

Market Cap

146.71B

Price-Earnings Ratio

—

Dividend Yield

2.77

Average Volume

13.41M

High Today

$67.16

Low Today

$66.33

Open Price

$66.92

Volume

10.85M

52 Week High

$68.34

52 Week Low

$45.76

Collections

Pharmaceutical

Biopharmaceutical

Manufacturing

Research And Development

BMY News

BenzingaJan 15

Bristol-Myers Squibb's Debt Overview

Over the past three months, shares of Bristol-Myers Squibb (NYSE: BMY) moved higher by 8.86%. Before having a look at the importance of debt, let us look at how

Analyst Ratings

68%

of 19 ratings

Buy

68%

Hold

32%

Sell

BMY Earnings

$0.00

$0.57

$1.15

$1.72

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Feb 4, Pre-Market